Published in J Mol Cell Cardiol on October 01, 2000
Mammalian Krüppel-like factors in health and diseases. Physiol Rev (2010) 4.09
MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation (2010) 2.32
Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia. Immunology (2006) 2.26
Matricellular proteins in cardiac adaptation and disease. Physiol Rev (2012) 2.01
mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy. Am J Physiol Cell Physiol (2010) 1.92
MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure. Aging Cell (2011) 1.84
Connective tissue growth factor promotes fibrosis downstream of TGFbeta and IL-6 in chronic cardiac allograft rejection. Am J Transplant (2009) 1.59
Differential expression of microRNAs in different disease states. Circ Res (2012) 1.30
Matrix metalloproteinase-9 deletion attenuates myocardial fibrosis and diastolic dysfunction in ageing mice. Cardiovasc Res (2012) 1.25
The Kruppel-like factor KLF15 inhibits connective tissue growth factor (CTGF) expression in cardiac fibroblasts. J Mol Cell Cardiol (2008) 1.25
Phosphoinositide-3 kinase signaling in cardiac hypertrophy and heart failure. Curr Pharm Des (2011) 1.16
Hypoxia induces expression of connective tissue growth factor in scleroderma skin fibroblasts. Clin Exp Immunol (2006) 1.12
Connective tissue growth factor as a mediator of intraocular fibrosis. Invest Ophthalmol Vis Sci (2008) 1.11
Cell communications in the heart. Circulation (2010) 1.09
Transforming growth factor-beta receptor antagonism attenuates myocardial fibrosis in mice with cardiac-restricted overexpression of tumor necrosis factor. Basic Res Cardiol (2007) 1.08
Importance of myocyte-nonmyocyte interactions in cardiac development and disease. Circ Res (2012) 1.07
Targeted deletion of the extracellular signal-regulated protein kinase 5 attenuates hypertrophic response and promotes pressure overload-induced apoptosis in the heart. Circ Res (2010) 1.06
Increased connective tissue growth factor associated with cardiac fibrosis in the mdx mouse model of dystrophic cardiomyopathy. Int J Exp Pathol (2010) 1.05
TGF-β signalling and reactive oxygen species drive fibrosis and matrix remodelling in myxomatous mitral valves. Cardiovasc Res (2013) 1.04
Uptake and intracellular transport of the connective tissue growth factor: a potential mode of action. Biochem J (2001) 1.03
Diastolic dysfunction is associated with cardiac fibrosis in the senescence-accelerated mouse. Am J Physiol Heart Circ Physiol (2011) 1.03
Angiotensin II induces connective tissue growth factor gene expression via calcineurin-dependent pathways. Am J Pathol (2003) 1.03
Cross talk between cardiac myocytes and fibroblasts: from multiscale investigative approaches to mechanisms and functional consequences. Am J Physiol Heart Circ Physiol (2012) 1.02
The cholesterol metabolite 25-hydroxycholesterol activates estrogen receptor α-mediated signaling in cancer cells and in cardiomyocytes. PLoS One (2011) 1.01
Defective myofibroblast formation from mesenchymal stem cells in the aging murine heart rescue by activation of the AMPK pathway. Am J Pathol (2011) 1.00
Vascular wall extracellular matrix proteins and vascular diseases. Biochim Biophys Acta (2014) 0.99
ATP released from cardiac fibroblasts via connexin hemichannels activates profibrotic P2Y2 receptors. FASEB J (2012) 0.98
Exercise training reduces fibrosis and matrix metalloproteinase dysregulation in the aging rat heart. FASEB J (2010) 0.97
Identification of human ccn2 (connective tissue growth factor) promoter polymorphisms. Mol Pathol (2001) 0.95
TGF-beta, IL-6, IL-17 and CTGF direct multiple pathologies of chronic cardiac allograft rejection. Immunotherapy (2010) 0.92
Pathophysiological defects and transcriptional profiling in the RBM20-/- rat model. PLoS One (2013) 0.91
Genetic Analysis of Connective Tissue Growth Factor as an Effector of Transforming Growth Factor β Signaling and Cardiac Remodeling. Mol Cell Biol (2015) 0.90
Autoantibody against matrix metalloproteinase-3 in patients with systemic sclerosis. Clin Exp Immunol (2004) 0.90
Regulation of connective tissue growth factor gene expression and fibrosis in human heart failure. J Card Fail (2013) 0.90
Myocardial connective tissue growth factor (CCN2/CTGF) attenuates left ventricular remodeling after myocardial infarction. PLoS One (2012) 0.90
Up-regulation of BMP-2 antagonizes TGF-β1/ROCK-enhanced cardiac fibrotic signalling through activation of Smurf1/Smad6 complex. J Cell Mol Med (2012) 0.90
Targeted deletion of ERK2 in cardiomyocytes attenuates hypertrophic response but provokes pathological stress induced cardiac dysfunction. J Mol Cell Cardiol (2014) 0.89
Lamina-associated polypeptide 2alpha loss impairs heart function and stress response in mice. Circ Res (2009) 0.89
Cardiac Extracellular Vesicles in Normal and Infarcted Heart. Int J Mol Sci (2016) 0.88
Cancer-associated fibroblasts as targets for immunotherapy. Immunotherapy (2012) 0.88
MicroRNA signature in wound healing following excimer laser ablation: role of miR-133b on TGFβ1, CTGF, SMA, and COL1A1 expression levels in rabbit corneal fibroblasts. Invest Ophthalmol Vis Sci (2013) 0.88
Plasma CCN2/connective tissue growth factor is associated with right ventricular dysfunction in patients with neuroendocrine tumors. BMC Cancer (2010) 0.88
Increased fibronectin deposition in embryonic hearts of retinol-binding protein-null mice. Circ Res (2003) 0.88
Snail as a potential target molecule in cardiac fibrosis: paracrine action of endothelial cells on fibroblasts through snail and CTGF axis. Mol Ther (2013) 0.87
Connective tissue growth factor modulates extracellular matrix production in human subconjunctival fibroblasts and their proliferation and migration in vitro. Jpn J Ophthalmol (2008) 0.86
Aldosterone upregulates connective tissue growth factor gene expression via p38 MAPK pathway and mineralocorticoid receptor in ventricular myocytes. J Korean Med Sci (2004) 0.86
Transient receptor potential (TRP) channels and cardiac fibrosis. Curr Top Med Chem (2013) 0.84
ALK-5 mediates endogenous and TGF-beta1-induced expression of connective tissue growth factor in embryonic lung. Am J Respir Cell Mol Biol (2006) 0.84
Regulation of Connective Tissue Growth Factor and Cardiac Fibrosis by an SRF/MicroRNA-133a Axis. PLoS One (2015) 0.84
The role of TGFβ1 and LRG1 in cardiac remodelling and heart failure. Biophys Rev (2015) 0.83
Novel mechanism of cardiac protection by valsartan: synergetic roles of TGF-β1 and HIF-1α in Ang II-mediated fibrosis after myocardial infarction. J Cell Mol Med (2015) 0.83
MnSOD overexpression reduces fibrosis and pro-apoptotic signaling in the aging mouse heart. J Gerontol A Biol Sci Med Sci (2014) 0.82
The function of miRNA in cardiac hypertrophy. Cell Mol Life Sci (2012) 0.82
Effect of selenium-deficient diet on tubular epithelium in normal rats. Pediatr Nephrol (2006) 0.82
Effect of connective tissue growth factor on protein kinase expression and activity in human corneal fibroblasts. Invest Ophthalmol Vis Sci (2012) 0.82
Lysophosphatidic Acid Upregulates Laminin-332 Expression during A431 Cell Colony Dispersal. J Oncol (2010) 0.81
Acute targeting of general transcription factor IIB restricts cardiac hypertrophy via selective inhibition of gene transcription. Circ Heart Fail (2014) 0.81
CCN2 exerts direct cytoprotective actions in adult cardiac myocytes by activation of the PI3-kinase/Akt/GSK-3β signaling pathway. J Cell Commun Signal (2012) 0.81
Regulation of connective tissue growth factor (ccn2; ctgf) gene expression in human mesangial cells: modulation by HMG CoA reductase inhibitors (statins). Mol Pathol (2001) 0.81
Endoglin: a critical mediator of cardiovascular health. Vasc Health Risk Manag (2013) 0.81
Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension. Int J Mol Sci (2016) 0.80
Syndecan-4: a component of the mechanosensory apparatus of cardiac fibroblasts. J Mol Cell Cardiol (2012) 0.80
Long pentraxin PTX3 exacerbates pressure overload-induced left ventricular dysfunction. PLoS One (2013) 0.80
Evidence Supporting a Role for SMAD2/3 in Bovine Early Embryonic Development: Potential Implications for Embryotropic Actions of Follistatin. Biol Reprod (2015) 0.79
Recombinant expression, purification, and functional characterisation of connective tissue growth factor and nephroblastoma-overexpressed protein. PLoS One (2010) 0.79
ERK1/2 directly acts on CTGF/CCN2 expression to mediate myocardial fibrosis in cardiomyopathy caused by mutations in the lamin A/C gene. Hum Mol Genet (2016) 0.78
Molecular remodeling of left and right ventricular myocardium in chronic anthracycline cardiotoxicity and post-treatment follow up. PLoS One (2014) 0.78
Mediators leading to fibrosis - how to measure and control them in tissue engineering. Oper Tech Orthop (2010) 0.78
The CTGF gene -945 G/C polymorphism is not associated with cardiac or kidney complications in subjects with type 2 diabetes. Cardiovasc Diabetol (2012) 0.78
Bone Marrow-Derived Mesenchymal Stem Cells Repair Necrotic Pancreatic Tissue and Promote Angiogenesis by Secreting Cellular Growth Factors Involved in the SDF-1 α /CXCR4 Axis in Rats. Stem Cells Int (2015) 0.78
Tumor Necrosis Factor - Alpha Is Essential for Angiotensin II-Induced Ventricular Remodeling: Role for Oxidative Stress. PLoS One (2015) 0.78
Right ventricular myocardial performance index is decreased with severe pressure-overload cardiac hypertrophy in young rats. Pediatr Cardiol (2013) 0.77
Connective tissue growth factor in tear film of the horse: detection, identification and origin. Graefes Arch Clin Exp Ophthalmol (2003) 0.77
The role of epigenetics in the fibrotic processes associated with glaucoma. J Ophthalmol (2014) 0.77
Connective tissue growth factor regulates cardiac function and tissue remodeling in a mouse model of dilated cardiomyopathy. J Mol Cell Cardiol (2015) 0.77
High-salt intake suppressed microRNA-133a expression in Dahl SS rat myocardium. Int J Mol Sci (2014) 0.76
Protease-Activated Receptor 1 Contributes to Angiotensin II-Induced Cardiovascular Remodeling and Inflammation. Cardiology (2016) 0.76
Circulating Biomarkers Predictive of Postoperative Atrial Fibrillation. Cardiol Rev (2016) 0.76
The Role of the Rho/ROCK Pathway in Ang II and TGF-β1-Induced Atrial Remodeling. PLoS One (2016) 0.75
KLF15 and cardiac fibrosis: the heart thickens. J Mol Cell Cardiol (2008) 0.75
Preventative effect of Astragalus flavescens on hepatic fibrosis in rats and its mechanism of action. Exp Ther Med (2013) 0.75
Simvastatin ameliorates low-dose streptozotocin-induced type 2 diabetic nephropathy in an experimental rat model. Int J Clin Exp Med (2015) 0.75
Increased Epithelial Expression of CTGF and S100A7 with Elevated Subepithelial Expression of IL-1β in Trachomatous Trichiasis. PLoS Negl Trop Dis (2016) 0.75
Renal Sympathetic Denervation in Rats Ameliorates Cardiac Dysfunction and Fibrosis Post-Myocardial Infarction Involving MicroRNAs. Med Sci Monit (2016) 0.75
Gene expression comparison reveals distinct basal expression of HOX members and differential TNF-induced response between brain- and spinal cord-derived microvascular endothelial cells. J Neuroinflammation (2016) 0.75
Experimental Mouse Model of Lumbar Ligamentum Flavum Hypertrophy. PLoS One (2017) 0.75
Epigenetic regulation in cardiac fibrosis. World J Cardiol (2015) 0.75
Effect and Mechanism of QiShenYiQi Pill on Experimental Autoimmune Myocarditis Rats. Med Sci Monit (2016) 0.75
Developmental stage-dependent effects of cardiac fibroblasts on function of stem cell-derived engineered cardiac tissues. Sci Rep (2017) 0.75
miR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal Transition: Therapeutic Implications in Kawasaki Disease. Circ Res (2016) 0.75
Evaluation of circulating levels of CCN2/connective tissue growth factor in patients with ST-elevation myocardial infarction. Sci Rep (2017) 0.75
Fibroblast deletion of ROCK2 attenuates cardiac hypertrophy, fibrosis, and diastolic dysfunction. JCI Insight (2017) 0.75
Fibroblast Growth Factor 2 as an Antifibrotic: Antagonism of Myofibroblast Differentiation and Suppression of Pro-Fibrotic Gene Expression. Cytokine Growth Factor Rev (2017) 0.75
Metformin ameliorates diabetic nephropathy in a rat model of low-dose streptozotocin-induced diabetes. Exp Ther Med (2017) 0.75
The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem (1991) 7.22
Homothallic switching of yeast mating type cassettes is initiated by a double-stranded cut in the MAT locus. Cell (1982) 7.00
A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science (1991) 5.14
Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science (1986) 5.12
Membrane and cytoplasmic changes in B lymphocytes induced by ligand-surface immunoglobulin interaction. Adv Immunol (1976) 4.18
Human basic fibroblast growth factor: nucleotide sequence and genomic organization. EMBO J (1986) 3.35
Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature (1987) 3.27
Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci U S A (1989) 3.24
A mononuclear cell component in experimental immunological glomerulonephritis. J Exp Med (1978) 3.02
Altered patterns of gene expression in response to myocardial infarction. Circ Res (2000) 2.76
Involvement of double-strand chromosomal breaks for mating-type switching in Saccharomyces cerevisiae. Cold Spring Harb Symp Quant Biol (1984) 2.64
Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein. J Biol Chem (1992) 2.37
Redistribution of myosin accompanying capping of surface Ig. J Exp Med (1977) 2.18
Coagulation studies in ulcerative colitis and Crohn's disease. Gastroenterology (1975) 2.08
Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate. J Cell Biol (1993) 2.02
Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol (2001) 1.98
Comparison of flow and velocity during dynamic autoregulation testing in humans. Stroke (1994) 1.92
Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family. Biochem Biophys Res Commun (1989) 1.91
Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways. Oncogene (2001) 1.91
Effects of therapy in X-linked hypophosphatemic rickets. N Engl J Med (1991) 1.90
Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol (2001) 1.90
Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. Proc Natl Acad Sci U S A (1989) 1.83
Anti-Ig-triggered movements of lymphocytes-specificity and lack of evidence for directional migration. J Immunol (1975) 1.82
Rapid induction of heparin-binding epidermal growth factor/diphtheria toxin receptor expression by Raf and Ras oncogenes. Genes Dev (1995) 1.79
Calcium-sensitive modulation of Ig capping: evidence supporting a cytoplasmic control of ligand-receptor complexes. J Exp Med (1976) 1.75
Characterization of resident glomerular cells in the rat expressing Ia determinants and manifesting genetically restricted interactions with lymphocytes. J Clin Invest (1981) 1.72
Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney Int (2000) 1.72
The presence of fibroblast growth factor in the frog egg: its role as a natural mesoderm inducer. Science (1988) 1.64
Local extrahepatic expression of complement genes C3, factor B, C2, and C4 is increased in murine lupus nephritis. J Clin Invest (1988) 1.60
Chemotaxis of rat lymphocytes. J Immunol (1977) 1.53
Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis (2001) 1.52
Safety and comfort during sedation for diagnostic or therapeutic procedures. Hong Kong Med J (2002) 1.48
Detection and identification of mycobacteria in fixed stained smears and formalin-fixed paraffin-embedded tissues using PCR. J Small Anim Pract (2013) 1.47
Vesicoureteric reflux and timing of micturating cystourethrography after urinary tract infection. Arch Dis Child (1997) 1.46
The disruption of immunoglobulin caps by local anesthetics. Clin Immunol Immunopathol (1976) 1.46
Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy. Kidney Int (2001) 1.40
Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR). Eur Psychiatry (2009) 1.38
Basic fibroblast growth factor in human rhabdomyosarcoma cells: implications for the proliferation and neovascularization of myoblast-derived tumors. Proc Natl Acad Sci U S A (1987) 1.38
Spontaneous redistribution of surface immunoglobulin in the motile B lymphocyte. J Exp Med (1976) 1.31
Natriuretic and diuretic actions of a highly selective adenosine A1 receptor antagonist. J Am Soc Nephrol (1999) 1.28
Post-cyclosporine-mediated hypertension and nephropathy: amelioration by vascular endothelial growth factor. Am J Physiol Renal Physiol (2001) 1.27
Modulation of Ia and leukocyte common antigen expression in rat glomeruli during the course of glomerulonephritis and aminonucleoside nephrosis. Lab Invest (1984) 1.27
Origin of the rat mesangial phagocyte and its expression of the leukocyte common antigen. Lab Invest (1984) 1.26
Mechanism of cytokine inhibition of beta-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes. Impairment of signal transduction. Circ Res (1990) 1.26
Production of heparin binding epidermal growth factor-like growth factor in the early phase of regeneration after acute renal injury. Isolation and localization of bioactive molecules. J Clin Invest (1997) 1.22
Basic fibroblast growth factor stimulation of epidermal wound healing in pigs. J Invest Dermatol (1990) 1.22
Outcomes in persistent hyperplastic primary vitreous. Br J Ophthalmol (2005) 1.22
Biosynthesis and processing by phorbol ester of the cells surface-associated precursor form of heparin-binding EGF-like growth factor. Biochem Biophys Res Commun (1994) 1.20
Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor. Circ Res (2000) 1.20
Measurement of the negative muon anomalous magnetic moment to 0.7 ppm. Phys Rev Lett (2004) 1.19
False-negative results using Neisseria gonorrhoeae porA pseudogene PCR - a clinical gonococcal isolate with an N. meningitidis porA sequence, Australia, March 2011. Euro Surveill (2011) 1.13
Role of outer ring carboxylates of the rat skeletal muscle sodium channel pore in proton block. J Physiol (2002) 1.12
Addition of growth hormone secretion signal to basic fibroblast growth factor results in cell transformation and secretion of aberrant forms of the protein. Oncogene (1988) 1.11
Use of ultrasonography in the diagnosis of childhood pilomatrixoma. Pediatr Dermatol (2000) 1.10
Contribution of proteinuria to progressive renal injury: consequences of tubular uptake of fatty acid bearing albumin. Am J Nephrol (1993) 1.09
Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes. Proc Natl Acad Sci U S A (1994) 1.09
Heparin-binding epidermal growth factor-like growth factor expression in cultured fetal human vascular smooth muscle cells. Induction of mRNA levels and secretion of active mitogen. J Biol Chem (1993) 1.07
Macrophages and renal disease. Lab Invest (1994) 1.07
The modulation of spontaneous and anti-Ig-stimulated motility of lymphocytes by cyclic nucleotides and adrenergic and cholinergic agents. J Immunol (1975) 1.06
Ultrasonographic demonstration of a type 1 omphalomesenteric duct remnant. Acta Radiol (2006) 1.06
Capping and the lymphocyte: models for membrane reorganization. J Immunol (1977) 1.05
Localization of an Ia-bearing glomerular cell in the mesangium. J Cell Biol (1982) 1.05
Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo. Leukemia (2006) 1.04
Immune mechanisms of cardiac disease. N Engl J Med (1994) 1.04
The genes for basic and acidic fibroblast growth factors are on different human chromosomes. Biochem Biophys Res Commun (1986) 1.01
Characterization of the hormone-sensitive Ca2+ uptake activity of the hepatic endoplasmic reticulum. Biochim Biophys Acta (1980) 1.01
Glucocorticoid inhibits thrombin-induced expression of platelet-derived growth factor A-chain and heparin-binding epidermal growth factor-like growth factor in human aortic smooth muscle cells. J Biol Chem (1993) 1.01
Application of in vitro-in vivo correlations (IVIVC) in setting formulation release specifications. Biopharm Drug Dispos (2000) 0.98
Eosinophils expressing heparin-binding EGF-like growth factor mRNA localize around lung microvessels in pulmonary hypertension. Am J Pathol (1993) 0.98
Hypothesis: the role of acquired tubulointerstitial disease in the pathogenesis of salt-dependent hypertension. Kidney Int (1997) 0.98
VEGF(121)- and bFGF-induced increase in collateral blood flow requires normal nitric oxide production. Am J Physiol Heart Circ Physiol (2001) 0.97
Improvement of human islet cryopreservation by a p38 MAPK inhibitor. Am J Transplant (2007) 0.97
Heparin-binding EGF-like growth factor contributes to reduced glomerular filtration rate during glomerulonephritis in rats. J Clin Invest (2000) 0.97
Differential regulation of heparin-binding epidermal growth factor-like growth factor in the adult ovariectomized mouse uterus by progesterone and estrogen. Endocrinology (1994) 0.96
Purification and characterization of transmembrane forms of heparin-binding EGF-like growth factor. J Biol Chem (1994) 0.96
Involvement of wound-associated factors in rat brain astrocyte migratory response to axonal injury: in vitro simulation. J Clin Invest (1996) 0.95
Immune cytokine inhibition of beta-adrenergic agonist stimulated cyclic AMP generation in cardiac myocytes. Biochem Biophys Res Commun (1988) 0.95
Anomalous staining of membrane lipids on acrylamide gels. Anal Biochem (1972) 0.95
Matrix metalloproteinases contribute to endotoxin and interleukin-1beta induced vascular dysfunction. Br J Pharmacol (2006) 0.94
Essential fatty acid deficiency ameliorates acute renal dysfunction in the rat after the administration of the aminonucleoside of puromycin. J Clin Invest (1990) 0.93
Inhibition of the mitogen activated protein kinase, p38 alpha, prevents proinflammatory cytokine induction by human adherent mononuclear leukocytes in response to lipid loading. Atherosclerosis (2001) 0.93
Metabolic effects of fatty acid-bearing albumin on a proximal tubule cell line. Am J Physiol (1995) 0.93
Complement gene expression in hepatic and extrahepatic tissues of NZB and NZB x W (F1) mouse strains. Immunology (1990) 0.92
Diagnostic accuracy of surgeon-performed focused abdominal sonography (FAST) in blunt paediatric trauma. Injury (2005) 0.92
[Posterior chamber implantation in black Africa. Apropos of 150 cases with an 18 months follow-up]. J Fr Ophtalmol (1993) 0.92
Renal uptake of an 18-mer phosphorothioate oligonucleotide. Kidney Int (1995) 0.91
Basic fibroblast growth factor: production and growth stimulation in cultured adrenal cortex cells. Endocrinology (1987) 0.91
Effects of probucol on renal function in rats with bilateral ureteral obstruction. Kidney Int (1990) 0.91
Tubular catabolism of albumin is associated with the release of an inflammatory lipid. Kidney Int (1994) 0.91
The concepts of family doctor and factors affecting choice of family doctors among Hong Kong people. Hong Kong Med J (2010) 0.90
Patient morbidity and management patterns of community-based primary health care services in Hong Kong. Hong Kong Med J (2011) 0.90
Measurement of midfemoral shaft geometry: repeatability and accuracy using magnetic resonance imaging and dual-energy X-ray absorptiometry. J Bone Miner Res (2001) 0.90
Structural analysis of the gene for human acidic fibroblast growth factor. Biochem Biophys Res Commun (1989) 0.90
Renal cortical release of a specific macrophage chemoattractant in response to ureteral obstruction. Lab Invest (1990) 0.90